Samsung heir Lee on US trip for foundry investment, COVID vaccines

Lee’s US visit, his first in five years, signals his return to management, filling the void left by his imprisonment

Samsung Vice Chairman Jay Y. Lee leaves Sunday for Canada, US business trip
Samsung Vice Chairman Jay Y. Lee leaves Sunday for Canada, US business trip
Shin-Young Park 2
2021-11-14 20:36:48 nyusos@hankyung.com
Business & Politics

Jay Y. Lee, vice chairman and de facto leader of South Korea’s top conglomerate Samsung, has embarked on a business trip to North America to finalize the group’s plan to build another chip plant in the US and discuss COVID-19 vaccines with Moderna Inc.

Lee, who left the Gimpo airport near Seoul on Sunday morning, will head to Canada for a visit to Samsung’s artificial intelligence research center in Toronto before flying to the US, according to industry officials.

He will not be accompanied by his aides and other executives on his trip to Canada and the US, according to Samsung.

While in the US, he will meet with business leaders to finalize Samsung Electronics Co.'s 20 trillion won ($17 billion) project to build a new semiconductor foundry plant.

Taylor, a city in Texas' Williamson County, near Austin where the company’s current foundry facilities are located, is the most likely site for the new plant, but areas such as Phoenix, Arizona and upstate New York are also among candidates.

Samsung's Jay Y. Lee visits ASML in the Netherlands
Samsung's Jay Y. Lee visits ASML in the Netherlands

Samsung has been ramping up its investment in the US to better compete against foundry rivals such as Taiwan Semiconductor Manufacturing Company (TSMC), which announced earlier this year its plan to spend $12 billion until 2024 to build advanced foundry facilities in the US.

Lee’s US trip comes as global chipmakers are under pressure by the US administration to disclose internal information, even industrial secrets, as part of efforts to tackle the global chip shortage.

Lee could meet with US government officials and politicians to further explain Samsung’s chip business, according to industry sources.

Korea’s top business leaders recently made US trips while their companies moved to newly open their Washington offices to deal with regulatory and government issues as getting a firm handle on US policy trends and networking have become crucial to doing business in the US.

Moderna's COVID-19 vaccine
Moderna's COVID-19 vaccine

COVID VACCINE

During his stay in the US, Lee is also expected to visit Moderna’s headquarters in Boston to discuss vaccine supply issues.

Samsung’s pharmaceutical affiliate, Samsung Biologics Co., is in partnership with Moderna to make vaccines for the US company under a contract manufacturing organization (CMO) service.

Last month, Samsung Biologics said its Moderna COVID vaccine produced in Korea will also be consumed for use in Korea.

Lee’s latest North American trip marks his first international trip since his release on parole in August. He was sentenced to two-and-a-half years in prison in January during a retrial of a bribery case involving former President Park Geun-hye.

His US visit also represents his first US trip in five years.

Write to Shin-Young Park at nyusos@hankyung.com
In-Soo Nam edited this article.

LG, CJ join other Korean firms to run offices in Washington

 LG, CJ join other Korean firms to run offices in Washington

Washington D.C. is becoming a key destination for Korean conglomerates. WASHINGTON D.C. – South Korea’s major business conglomerates are heading to Washington D.C. to run offices handling regulatory and government issues as gaining an understanding of the Biden administration’

Uncertainty clouds Samsung as paradigm shifts toward profitability

Uncertainty clouds Samsung as paradigm shifts toward profitability

Workers at a chipmaker's clean room Samsung Electronics Co.’s third-quarter earnings report on Thursday was almost perfect but for one thing. The world’s top memory maker skipped the routine capital expenditure plans and industry outlook, citing uncertainty.The South Korean tech gia

Samsung Biologics-made Moderna vaccine available to Koreans this week

Samsung Biologics-made Moderna vaccine available to Koreans this week

Researchers at Samsung Biologics' third plant in Songdo, Incheon Moderna Inc.’s COVID-19 vaccine first produced by Samsung Biologics Co. under a contract manufacturing organization (CMO) service will be available to South Koreans from this week.Some 2.43 million doses of the US company&rs

Samsung shares struggle as big strategic decisions still await Lee

Samsung shares struggle as big strategic decisions still await Lee

Samsung faces an uphill battle with rivals Shares of Samsung Electronics Co. have been trapped in a boxed range since the start of the year, dashing retail investors’ hope that the tech giant would easily top the psychologically important 100,000 won ($86.7) a share given the bullish indu

Samsung Electronics’ stock stages a rebound as outlook concerns ease

Samsung Electronics’ stock stages a rebound as outlook concerns ease

Samsung's stock is staging a meaningful rebound. Shares of Samsung Electronics Co. have risen above the psychologically important level as foreign and institutional investors returned amid easing concerns over the chip industry outlook.The largest stock on South Korea’s main Kospi market

Memory leader Samsung aims to strengthen system chips, foundry

Memory leader Samsung aims to strengthen system chips, foundry

Samsung's latest memory chipset Samsung Electronics Co. is forecast to keep its memory leadership amid growing competition, although the South Korean tech giant has some catching up to do in the system chip and foundry segments.According to market researcher Omdia, Samsung ranked first in the g

(* comment hide *}